Virani Shafique's Form 4 filing
Recursion Pharmaceuticals, Inc. (RXRX) · filed Feb 17, 2023
- Accession no.
- 0001209191-23-010774
- Filed
- Feb 17, 2023
- Trade date
- Feb 15-16, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $77.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Virani ShafiqueCIK 0001856081 | Officer (Chief Business Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2023 | Class A Common Stock | MOption exerciseAcquired | +7,486 | $2.22 | +$16,618.92 | 197,332 | Direct | |
| Feb 15, 2023 | Class A Common Stock | SSaleDisposed | −7,486 | $8.33 | −$62,358.38 | 189,846 | Direct | |
| Feb 15, 2023 | Class A Common Stock | FTax withholdingDisposed | −746 | $8.44 | −$6,296.24 | 189,100 | Direct | |
| Feb 16, 2023 | Class A Common Stock | SSaleDisposed | −1,768 | $8.42 | −$14,886.56 | 187,332 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2023 | Class A Common Stock | MOption exerciseAcquired | +7,486 | $0.00 | $0 | 629,469 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.